Eudaimonia Partners’s CapForce IBD Breakout Opportunities ETF BOUT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-962
Closed -$32K 497
2021
Q1
$32K Sell
962
-427
-31% -$14.7K 0.01% 782
2020
Q4
$44K Buy
1,389
+170
+14% +$4.65K 0.01% 641
2020
Q3
$29K Sell
1,219
-159
-12% -$3.74K 0.01% 697
2020
Q2
$31K Sell
1,378
-61
-4% -$1.26K 0.01% 609
2020
Q1
$26K Sell
1,439
-1,530
-52% -$30.8K 0.01% 597
2019
Q4
$62K Buy
+2,969
New +$58.9K 0.02% 443

Other funds holding BOUT

Eudaimonia Partners's BOUT Position: Q2 2021 in Review

Eudaimonia Partners sold out of CapForce IBD Breakout Opportunities ETF (BOUT) in Q2 2021, closing a stake of 962 shares — an estimated $32K sold.

Eudaimonia Partners first reported a position in BOUT in Q4 2019 and held it in 6 quarters. The position peaked at $62K in Q4 2019. 11 funds tracked by Wall St. Rank hold BOUT as of Q2 2021.

  • Eudaimonia Partners reported no remaining CapForce IBD Breakout Opportunities ETF position as of Q2 2021 after selling out during the quarter.
  • Eudaimonia Partners sold 962 CapForce IBD Breakout Opportunities ETF shares in Q2 2021, an estimated $32K.
  • Eudaimonia Partners first reported a position in CapForce IBD Breakout Opportunities ETF in Q4 2019 and held it in 6 quarters.
  • Eudaimonia Partners's CapForce IBD Breakout Opportunities ETF position peaked at $62K in Q4 2019.
  • 11 funds tracked by Wall St. Rank held CapForce IBD Breakout Opportunities ETF as of Q2 2021.

Based on Eudaimonia Partners's 13F filing for Q2 2021, filed 13 Aug 2021.